Also known as GH Fragment 176-191, AOD 9604 incorporates a tyrosine residue at the N-terminus that researchers suggest may contribute to the peptides stability in laboratory settings
Methods: The Behavioral Risk Factor Surveillance System (BRFSS) 2016to2022 was used
This can lead to fatigue or a loss of muscle mass, which is where targeted supplementation may play a role
Graphs were generated using GraphPad Prism version 10.4.2 (GraphPad Software, Boston, MA, USA) and R version 4.4.1 [R Core Team, 2024] in RStudio (Posit Software, PBC, Boston, MA, USA)
Conflict of interest The University of California, Davis holds multiple patents for the use of soluble epoxide hydrolase inhibitors in humans and companion animals